Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations

10.3324/haematol.2018.201483

Saved in:

Bibliographic Details
Main Authors:	Lim, S.L., Damnernsawad, A., Shyamsunder, P., Chng, W.J., Han, B.C., Xu, L., Pan, J., Pravin, D.P., Alkan, S., Tyner, J.W., Koeffler, H.P.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	Ferrata Storti Foundation 2021
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/209622
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-209622
record_format	dspace
spelling	sg-nus-scholar.10635-2096222024-04-17T09:34:21Z Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations Lim, S.L. Damnernsawad, A. Shyamsunder, P. Chng, W.J. Han, B.C. Xu, L. Pan, J. Pravin, D.P. Alkan, S. Tyner, J.W. Koeffler, H.P. CANCER SCIENCE INSTITUTE OF SINGAPORE DEAN'S OFFICE (MEDICINE) MEDICINE 10.3324/haematol.2018.201483 Haematologica 104 6 1209-1220 2021-12-06T04:28:03Z 2021-12-06T04:28:03Z 2019 Article Lim, S.L., Damnernsawad, A., Shyamsunder, P., Chng, W.J., Han, B.C., Xu, L., Pan, J., Pravin, D.P., Alkan, S., Tyner, J.W., Koeffler, H.P. (2019). Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations. Haematologica 104 (6) : 1209-1220. ScholarBank@NUS Repository. https://doi.org/10.3324/haematol.2018.201483 0390-6078 https://scholarbank.nus.edu.sg/handle/10635/209622 Attribution-NonCommercial 4.0 International https://creativecommons.org/licenses/by-nc/4.0/ Ferrata Storti Foundation Scopus OA2019
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.3324/haematol.2018.201483
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Lim, S.L. Damnernsawad, A. Shyamsunder, P. Chng, W.J. Han, B.C. Xu, L. Pan, J. Pravin, D.P. Alkan, S. Tyner, J.W. Koeffler, H.P.
format	Article
author	Lim, S.L. Damnernsawad, A. Shyamsunder, P. Chng, W.J. Han, B.C. Xu, L. Pan, J. Pravin, D.P. Alkan, S. Tyner, J.W. Koeffler, H.P.
spellingShingle	Lim, S.L. Damnernsawad, A. Shyamsunder, P. Chng, W.J. Han, B.C. Xu, L. Pan, J. Pravin, D.P. Alkan, S. Tyner, J.W. Koeffler, H.P. Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations
author_sort	Lim, S.L.
title	Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations
title_short	Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations
title_full	Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations
title_fullStr	Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations
title_full_unstemmed	Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations
title_sort	proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations
publisher	Ferrata Storti Foundation
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/209622
_version_	1800915179988320256

Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations

Similar Items